Imatinib mesylate
Imatinib Mesylate is an orally active, multi-targeted tyrosine kinase inhibitor that potently suppresses BCR-ABL, PDGFR, and c-Kit. It is a foundational research tool for studying oncogenic signaling and has demonstrated efficacy in both in vitro assays and in vivo models of chronic myeloid leukemia and other cancers.
Product Specifications
CAS Number
220127-57-1
Product Name Alternative
Gleevec; STI571
Field of Research
Cell Biology
Purity
>98%
Bioactivity
BCR-ABL inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 50 mg/ml) or in Water (up to 50 mg/ml) .
Smiles
CS (O) (=O) =O.CN1CCN (Cc2ccc (cc2) C (=O) Nc2ccc (C) c (Nc3nccc (n3) -c3cccnc3) c2) CC1
Molecular Formula
C29H31N7O ∙ CH3SO3H
Molecular Weight
493.62 ∙ 96.11
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
4-[ (4-Methyl-1-piperazinyl) methyl]-N-[4-methyl-3-[[4- (3-pyridinyl) -2-pyrimidinyl]amino]phenyl]benzamide methanesulfonate
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MART-1 (Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA, Melan-A) (Biotin)